You are here

Home » Content

SAĞLIK HİZMETLERİNDE ÖNCELİKLERİN BELİRLENMESİNDE EKONOMİK DEĞERLENDİRME YÖNTEMİ OLARAK MALİYET-ETKİLİLİK ANALİZİ

COST-EFFECTIVENESS ANALYSIS AS AN ECONOMIC EVALUATION METHOD FOR PRIORITY SETTING IN HEALTH SERVICES

Journal Name:

  • Süleyman Demirel Üniversitesi İktisadi ve İdari Bilimler Fakültesi Dergisi

Publication Year:

  • 2009
Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Due to increasing demand for health services and scarcity of resources allocated to this area, which health programs or technology should be given priority have become important. Therefore, the economic evaluation methods for priority setting has started to be widely used in recent years since they provide valuable information to decision makers and reduce uncertainty substantially. There is more than one economic evaluation method. The cost-effectiveness analysis is used more commonly in priority setting because it assesses the costs and outcomes of a health program together. Therefore, this study deals with the process of priority setting, and the cost-effectiveness analysis which is considered as one of the criteria in this process, as well as the application areas of cost-effectiveness analysis.
Bookmark/Search this post with
Abstract (Original Language): 
Sağlık hizmetlerine olan ihtiyacın artması ve bu alana ayrılan kaynakların sınırlı olması nedeniyle, hangi sağlık programlarına ya da teknolojilerine öncelik verileceği önemli hale gelmiştir. Bu yüzden önceliklerin belirlenmesinde ekonomik değerlendirme yöntemleri karar vericilere önemli bilgiler sunduğu ve belirsizliği önemli ölçüde azalttığı için yaygın olarak kullanılmaya başlanmıştır. Literatürde birden çok yöntem bulunmaktadır. Bu yöntemlerden maliyet-etkililik analizi bir sağlık programının maliyet ve sonuçlarını birlikte değerlendirdiğinden yaygın olarak kullanılmaktadır. Dolayısıyla, bu çalışmada önceliklerin belirlenmesi süreci ile bu süreçte kriterlerden biri olarak kabul edilen maliyet-etkililik analizi ve uygulama alanları sunulmaktadır.
FULL TEXT (PDF): 
PDF icon arastirmax-saglik-hizmetlerinde-onceliklerin-belirlenmesinde-ekonomik-degerlendirme-yontemi-olarak-maliyet-etkililik-analizi.pdf
  • 2
311-332
  • Turkish

REFERENCES

References: 

1. ANELL, A. "Priority setting for pharmaceuticals: the use of health economic evidence by reimbursement and clinical guidance committees" The European Journal of Health Economics, Vol. 5 (1), 2004, s. 28¬35.
2. BALTUSSEN, R. "Priority setting of public spending in developing countries: Do not try to do everything for everybody", Health Policy, 78, 2006, s. 149-156.
3. BALTUSSEN, R. ve NIESSEN, L. "Priority setting of health interventions: the need for multi-criteria decision analysis", Cost Effectiveness and Resource Allocation, 4:14, 2006, s. 1-9.
4. BROUWER, W. B. F. vd. "Welfarism vs. extra-welfarism", Journal of
Health Economics, 27, 2008, s. 325-338.
5. COAST, J. "Is economic evaluation in touch with society's health values?", British Medical Journal, 329, 2004, s. 1233-1236.
6. COAST, J. vd. "Welfarism, extra-welfarism and capability: The spread of ideas in health economics", Social Science and Medicine, 67, 2008, s. 1190-1198.
7. CORNAGO, D. vd. "Pharmacoeconomic studies in Italy: a critical review of the literature", The European Journal of Health Economics,
Vol. 8, 2007, s. 89-95.
8. CORNUZ, J. vd. "Cost-effectiveness analysis of the first-line therapies for nicotine dependence", European Journal of Clinical
Pharmacology, 59 (3), 2003, s. 201-206.
330
C.14, S.2
Sağlık Hizmetlerinde Önceliklerin Belirlenmesinde Ekonomik
9. COX, H. L. "Economic evaluation in critical care medicine", Journal of Critical Care, 21, 2006, s. 117-124.
10. CUNNINGHAM, S. J. "Economic evaluation of healthcare - is it important to us?", British Dental Journal, Vol.188 (5), 2000, s. 250¬254.
11. DRUMMOND, M. F. vd. Methods for the Economic Evaluation of
Health Care Programmes, New York, Oxford Medical Publications,
2005.
12. DRUMMOND, M. F. vd. "Economic evaluation", Singapore Med. Journal, 47(6), 2006, s. 456-461.
13. FOLLAND, S. vd. The Economics of Health and Health Care, New
York, Pearson Prentice Hall, 2006.
14. FOX-RUSHBY, J. A., ve HANSON, K. "Calculating and presenting disability adjusted life years (DALYs) in cost-effective analysis", Health Policy and Planning, 16 (3), 2001, s. 326-331.
15. GAFNI, A. ve BIRCH, S. "Incremental cost-effectiveness ratios (ICERs): The silence of the lambda" Social Science and Medicine, 62, 2006, s. 2091-2100.
16. GARBER, A. "Advances in cost-effectiveness analysis of health interventions", NBER Working Paper Series, No: 7198, 1999, http://www.nber.org/papers/w7198.
17. GARBER, A. M. ve PHELPS, C. E. "Economic foundations of cost-
effectiveness analysis", Journal of Health Economics, 16, 1997, s. 1¬31.
18. GOODACRE, S. ve McCABE, C. "An introduction to economic evaluation", The Emergency Medicine Journal, 19, 2002, s. 198-201.
19. HAM, C. "Priority setting in health care: learning from international
experience", Health Policy, 42, 1997, s. 49-66.
20. HAUCK, K. vd. "The Economics of Priority Setting for Health Care: A Literature Review", HNP Discussion Paper, Washington, The World
Bank. 2004.
21. HURLEY, J. "An Overview of the Normative Economics of the Health Sector", Culyer, A. J. ve Newhouse, J. P. (der.) Handbook of Health Economics içinde, Elsevier, Amsterdam, 2000, s. 55-110.
22. JÖNSSON, B. "Economic evaluation for pharmaceuticals in Germany", The European Journal of Health Economics, 8 (Suppl. 1), 2007, s. 1¬2.
23. KAMATH, C. C. vd. "The Cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis", Value in Health, Vol. 6 (2), 2001, s.144-157.
24. KAPIRIRI, L. ve NORHEIM, O. F. "Criteria for priority-setting in
health care in Uganda: exploration of stakeholders' values", Bulletin of the World Health Organization, 82 (3), 2004, s. 172-179.
331
ÇALIŞKAN
2009
25. KERNICK, D. "An introduction to the basic principles of health economics for those involved in the development and delivery of headache care", Cephalalgia, 25, 2005, s. 709-714.
26. KLARMAN, H. E. vd. "Cost-effectiveness analysis applied to the treatment of chronic renal disease", Medical Care, 6, 1968, s. 48-54.
27. KORTHALS-DE BOS, I. B. C. vd. "Cost-effectiveness of
physiotherapy, manual therapy, and general practitioner care for neck pain: economic evaluation alongside a randomized controlled trial",
British Medical Journal, Vol. 326, 2003, s. 1-6.
28. MELTZER, D. "Accounting for future costs in medical cost-effectiveness analysis", Journal of Health Economics, 16 (1), 1997, s.
33-64.
29. MITTON, C. R. "Priority setting for decision makers: using health economics in practice", The European Journal of Health Economics,
Vol. 3, No. 4, 2002, s. 240-243.
30. OECD Health a Glance OECD Indicators, Geneva, OECD, 2007.
31. PLEVRITIS, S. K. vd. "Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs. X-ray mammography of women at a high familial risk of breast cancer", British Journal of
Cancer, 95, 2006, s. 801-810.
32. ROBERTSON, M. C. vd "Effectiveness and economic evaluation of a nurse delivered home exercise programme to prevent falls. 1: Randomized controlled trial", British Medical Journal, Vol. 322, 2001,
s. 1-6.
33. ROBINSON, R. "Limits to rationality: economics, economists and
priority setting", Health Policy, 49, 1999, s. 13-26.
34. SABIK, L.M. ve LIE, K. R. "Priority setting in health care: Lessons from the experiences of eight countries", International Journal for
Equity in Health, 7:4, 2008, s. 1-13.
35. SCULPHER, M. vd. "It's just evaluation for decision making: recent developments in, and challenges for, cost-effectiveness research", Smith, P. C. vd. (der.) Health Policy and Economics: Opportunities and Challenges içinde, McGrawHill, Glasgow, 2005, s. 8-41.
36. VERKERK, M. A. vd "Health-related quality of life research and the capability approach of Amartya Sen", Quality of Life Research, Vol. 10 (1), 2001, s. 49-55.
37. WEINSTEIN, M. C. ve MANNING, W. G. Jr. "Theoretical issues in
cost-effectiveness analysis", Journal of Health Economics, 16, 1997, s.
121-128.
38. WHO The World Health Report 2000 - Health Systems: Improving
Performance, WHO, Geneva, 2000.

Thank you for copying data from http://www.arastirmax.com